Literature DB >> 23524941

PAK1-deficiency/down-regulation reduces brood size, activates HSP16.2 gene and extends lifespan in Caenorhabditis elegans.

S Yanase1, Y Luo, H Maruta.   

Abstract

There is an increasing evidence that the oncogenic kinase PAK1 is responsible not only for malignant transformation, but also for several other diseases such as inflammatory diseases (asthma and arthritis), infectious diseases including malaria, AIDS, and flu, as well as a series of neuronal diseases/disorders (neurofibromatosis, tuberous sclerosis, Alzheimer's diseases, Huntington's disease, epilepsy, depression, learning deficit, etc.) which often cause premature death. Interestingly, a few natural PAK1-blockers such as curcumin, caffeic acid (CA) and rosmarinic acid (RA) extend the lifespan of the nematode Caenorhabditis elegans or fruit flies. Here, to explore the possibility that C. elegans could provide us with a quick and inexpensive in vivo screening system for a series of more potent but safe (non-toxic) PAK1-blocking therapeutics, we examined the effects of PAK1-deficiency or down-regulation on a few selected functions of this worm, including reproduction, expression of HSP16.2 gene, and lifespan. In short, we found that PAK1 promotes reproduction, whereas it inactivates HSP16.2 gene and shortens lifespan, as do PI-3 kinase (AGE-1), TOR, and insulin-like signalling /ILS (Daf-2) in this worm. These findings not only support the "trade-off" theory on reproduction versus lifespan, but also suggest the possibility that the reduced reproduction (or HSP16.2 gene activation) of this worm could be used as the first indicator of extended lifespan for a quick in vivo screening for PAK1-blockers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23524941     DOI: 10.5582/ddt.2013.v7.1.29

Source DB:  PubMed          Journal:  Drug Discov Ther        ISSN: 1881-7831


  6 in total

1.  Glaucarubinone and gemcitabine synergistically reduce pancreatic cancer growth via down-regulation of P21-activated kinases.

Authors:  Dannel Yeo; Nhi Huynh; John A Beutler; Christopher Christophi; Arthur Shulkes; Graham S Baldwin; Mehrdad Nikfarjam; Hong He
Journal:  Cancer Lett       Date:  2014-01-31       Impact factor: 8.679

Review 2.  Effect of antioxidants supplementation on aging and longevity.

Authors:  Izabela Sadowska-Bartosz; Grzegorz Bartosz
Journal:  Biomed Res Int       Date:  2014-03-25       Impact factor: 3.411

3.  Glaucarubinone sensitizes KB cells to paclitaxel by inhibiting ABC transporters via ROS-dependent and p53-mediated activation of apoptotic signaling pathways.

Authors:  Subburayan Karthikeyan; Sugeerappa Laxmanappa Hoti; Yasin Nazeer; Harsha Vasudev Hegde
Journal:  Oncotarget       Date:  2016-07-05

Review 4.  Regulating Cdc42 and Its Signaling Pathways in Cancer: Small Molecules and MicroRNA as New Treatment Candidates.

Authors:  Xing-Hua Xiao; Lin-Chen Lv; Jing Duan; Ye-Meng Wu; Shu-Jin He; Zhen-Zhen Hu; Li-Xia Xiong
Journal:  Molecules       Date:  2018-03-29       Impact factor: 4.411

Review 5.  Artemisia scoparia and Metabolic Health: Untapped Potential of an Ancient Remedy for Modern Use.

Authors:  Anik Boudreau; Allison J Richard; Innocence Harvey; Jacqueline M Stephens
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-08       Impact factor: 5.555

6.  Anti-inflammatory property of propolis.

Authors:  Salvatore Chirumbolo
Journal:  J Clin Biochem Nutr       Date:  2015-02-07       Impact factor: 3.114

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.